Intestinal permeability studies of sulpiride incorporated into self-microemulsifying drug delivery system (SMEDDS)

Pakistan Journal of Pharmaceutical Sciences

Volumn 24, Issue 2, 2011, Pages 113-121

  Chitneni, Mallikarjun ^a,b   Peh, Kok Khiang ^b   Darwis, Yusrida ^b   Abdulkarim, Muthanna ^b   Abdullah, Ghassan Zuhair ^b   Qureshi, Mohammed Javed ^a  

^a INTERNATIONAL MEDICAL UNIVERSITY   (Malaysia)

^b SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

Author keywords

Effective permeability coefficient; Micellar solution; Single pass intestinal perfusion technique; SMEDDS; Sulpiride

Indexed keywords

SULPIRIDE;

ANIMAL EXPERIMENT; ARTICLE; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG SOLUTION; DUODENUM; EMULSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ILEUM; INTESTINE MUCOSA PERMEABILITY; INTESTINE PERFUSION; JEJUNUM; MALE; MICELLE; NONHUMAN; RAT;

ANIMALS; DRUG DELIVERY SYSTEMS; DRUG STABILITY; EMULSIONS; INTESTINAL ABSORPTION; MALE; MICELLES; PARTICLE SIZE; PERMEABILITY; RATS; RATS, SPRAGUE-DAWLEY; SULPIRIDE;

EID: 79953842924     PISSN: 1011601X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Amidon GL, Lennernas H, Shah VP and Crison JR (1995). A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm.Res., 12: 413-420.
2. Baluom M, Friedman M and Rubinstein A (2001). Improved intestinal absorption of sulpiride in rats with synchronized oral delivery systems. J. Control. Release., 70: 139-147. (Pubitemid 32144798)
3. Bressolle F, Bres J and Faure-Jeantis A (1992). Absolute bioavailability, rate of absorption, and dose proportionality of sulpiride in humans. J. Pharm. Sci., 81: 26-32.
4. Cao X, Yu LX, Barbaciru C, Landowski CP, Shin HC, Gibbs S, Miller HA, Amidon GL and Sun D (2005). Permeability dominates in vivo intestinal absorption of P-gp substrate with high solubility and high permeability. Mol. Pharm., 2: 329-340. (Pubitemid 41186409)
5. Chitneni M, Janagama S, Khiang PK and Yusrida D (2010). Bioavailability enhancement of sulpiride by self-microemulsifying drug delivery system. Lat. Am. J. Pharm., 29: 511-519.
6. Constantinides PP and Scalart JP (1997). Formulation and physical characterisation of water-in-oil microemulsions containing long- versus medium-chain glycerides. Int. J. Pharm., 158: 57-68. (Pubitemid 27504474)
7. Cooney GF, Jeevanandam V, Choudhury S, Feutren G, Mueller EA and Eisen HJ (1998). Comparative bioavailability of Neoral and Sandimmune in cardiac transplant recipients over 1 year. Transplant Proc., 30: 1892-1894. (Pubitemid 28399359)
8. Craig DQM, Barker SA, Banning D and Booth SW (1995). An investigation into the mechanisms of selfemulsification using particle size analysis and low frequency dielectric spectroscopy. Int. J. Pharm., 114: 103-110. (Pubitemid 24377034)
9. Fagerholm U, Johansson M and Lennernas H (1996). Comparison between permeability coefficients in rat and human jejunum. Pharm. Res., 13: 1336-1342. (Pubitemid 26344978)
10. Fotaki N, Symillides M and Reppas C (2005). Canine versus in vitro data for predicting input profiles of Lsulpiride after oral administration. Eur. J. Pharm. Sci., 26: 324-333. (Pubitemid 41278638)
11. Gursoy RN and Benita S (2004). Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed. Pharmacother., 58: 173-182. (Pubitemid 38479922)
12. Huang MC, Ho HO, Yeh GC, Ke WT, Lin LC, Hsu TM, Kao CC and Sheu MT (2001). Development of a highperformance liquid chromatographic method for bioanalytical applications with sulpiride. J. Chromatogr. B Biomed. Sci. Appl., 763: 157-163.
13. Issa C, Gupta P and Bansal AK (2003). Implications of density correction in gravimetric method for water flux determination using rat single-pass intestinal perfusion technique: A technical note. AAPS PharmSciTech., 4: article 16.
14. Kararli TT (1995). Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals. Biopharm. Drug Dispos., 16: 351-380.
15. Khoo SM, Humberstone AJ, Porter CJH, Edwards GA and Charman WN (1998). Formulation design and bioavailability assessment of lipidic self-emulsifying formulations of halofantrine. Int. J. Pharm., 167: 155-164. (Pubitemid 28341517)
16. Kim HJ, Yoon KA, Hahn MK, Park ES and Chi SC (2000). Preparation and In vitro evaluation of selfmicroemulsifying drug delivery systems containing idebenon. Drug Develop. Ind. Pharm., 26: 523-529. (Pubitemid 30225630)
17. Kohri N, Naasani I, Iseki K and Miyazaki K (1996). Improving the oral bioavailability of sulpiride by a gastric-retained form in rabbits. J. Pharm. Pharmacol., 48: 371-374. (Pubitemid 26185707)
18. Komiya I, Park JY, Kamani A, Ho NFH and Higuchi WI (1980). Quantitative mechanistic studies in simultaneous fluid flow and intestinal absorption using steroids as model solutes. Int. J. Pharm., 4: 249-262. (Pubitemid 10114888)
19. Laurent S, Kelly C, Lin P, Ken T and Lori T (2001). Evaluation of a single-pass intestinal- perfusion method in rat for the prediction of absorption in man. J. Pharm. Pharmacol., 53: 1007-1013.
20. Liu Z, Wang S and Hu M (2009). Oral absorption basics: pathways, physico-chemical and biological factors affecting absorption. In: Qiu Y, Chen Y and Zhang GGZ (Eds.) Developing solid oral dosage forms: Pharmaceutical theory and practice. Elsevier, MA, USA, pp.265-266.
21. Lo Y-L (2003). Relationships between the hydrophiliclipophilic balance values of pharmaceutical excipients and their multidrug resistance modulating effect in Caco-2 cells and rat intestines. J. Control. Release., 90: 37-48. (Pubitemid 36588877)
22. Parikh T, Bommana MM and Squillante III E (2009). Efficacy of surface charge in targeting pegylated nanoparticles of sulpiride to the brain. Eur. J. Pharm. Biopharm., doi:10.1016/j.ejpb.2009.11.001.
23. Patel D and Sawant KK (2007). Oral bioavailability enhancement of acyclovir by self-microemulsifying drug delivery systems (SMEDDS). Drug Dev. Ind. Pharm., 33: 1318-1326.
24. Porter CJ and Charman WN (2001). In vitro assessment of oral lipid based formulations. Adv. Drug Deliv. Rev., 50: S127-S147. (Pubitemid 32905359)
25. Porter CJ, Kaukonen AM, Boyd BJ, Edwards GA and Charman WN (2004). Susceptibility to lipase-mediated digestion reduces the oral bioavailability of danazol after administration as a medium-chain lipid-based microemulsion formulation. Pharm. Res., 21: 1405-1412. (Pubitemid 39149655)
26. Quan DQ, Xu GX and Wu XG (2007). Studies on preparation and absolute bioavailability of a selfemulsifying system containing puerarin. Chem. Pharm. Bull., 55: 800-803.
27. Rangel-Yagui CO, Pessoa A, JR and Tavares LC (2005). Micellar solubilization of drugs. J. Pharm. Pharm. Sci., 8: 147-165.
28. Rinaki E, Valsami G and Macheras P (2003). Quantitative biopharmaceutics classification system: the central role of dose/solubility ratio. Pharm. Res., 20: 1917-1925. (Pubitemid 38005521)
29. Sachan NK, Bhattacharya A, Pushkar S and Mishra A (2009). Biopharmaceutical classification system: A strategic tool for oral drug delivery technology. Asian J. Pharm., 3: 76-81.
30. Shah NH, Carvajal MT, Patel CI, Infield MH and Malick AW (1994). Self emulsifying drug delivery systems (SEDDS) with polyglycolized glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs. Int. J. Pharm., 106: 15-23. (Pubitemid 24110060)
31. Shen H and Zhong M (2006). Preparation and evaluation of self-microemulsifying drug delivery systems (SMEDDS) containing atorvastatin. J. Pharm. Pharmacol., 58: 1183-1191. (Pubitemid 44329099)
32. Shono Y, Nishihara H, Matsuda Y, Furukawa S, Okada N, Fujita T and Yamamoto A (2004). Modulation of intestinal P-glycoprotein function by cremophor EL and other surfactants by an in vitro diffusion chamber method using the isolated rat intestinal membranes. J. Pharm. Sci., 93: 877-885. (Pubitemid 38420399)
33. Singh AK, Chaurasiya A, Awasthi A, Mishra G, Asati D, Khar RK and Mukherjee R (2009). Oral bioavailability enhancement of exemestane from self-microemulsifying drug delivery system (SMEDDS). AAPS PharmSciTech., 10: 906-916.
34. Sinko PJ, Hu P, Waclawski AP and Patel NR (1995). Oral absorption of anti- AIDS nucleoside analogues. 1. Intestinal transport of didanosine in rat and rabbit preparations. J. Pharm. Sci., 84: 959-965.
35. Song NN, Li QS and Liu CX (2006). Intestinal permeability of metformin using single-pass intestinal perfusion in rats. World J. Gastroenterol., 12: 4064-4070.
36. Sutton SC, Rinaldi MT and Vukovinsky KE (2001). Comparison of the gravimetric, phenol red, and 14CPEG- 3350 methods to determine water absorption in the rat single-pass intestinal perfusion model. AAPS PharmSci., 3: E25.
37. Svensson US, Sandstrom R, Carlborg O, Lennernas H and Ashton M (1999). High in situ rat intestinal permeability of artemisinin unaffected by multiple dosing and with no evidence of P-glycoprotein involvement. Drug Metab. Dispos., 27: 227-232. (Pubitemid 29072076)
38. Swenson ES and Curatolo WJ (1992). Intestinal permeability enhancement for proteins, peptides and other polar drugs: mechanisms and potential toxicity. Adv. Drug Deliv. Rev., 8: 39-92.
39. Tang J, Sun J and He Z (2007). Self-emulsifying drug delivery systems: Strategy for improving oral delivery of poorly soluble drugs. Curr. Drug Ther., 2: 85-93. (Pubitemid 46723141)
40. Watanabe K, Sawano T, Jinriki T and Sato J (2004). Studies on intestinal absorption of sulpiride (3): intestinal absorption of sulpiride in rats. Biol. Pharm. Bull., 27: 77-81. (Pubitemid 41656677)
41. Wu W, Wang Y and Que L (2006). Enhanced bioavailability of silymarin by self-microemulsifying drug delivery system. Eur. J. Pharm. Biopharm., 63: 288-294. (Pubitemid 43776222)
42. Yang JM, Chin KV and Hait WN (1996). Interaction of Pglycoprotein with protein kinase C in human multidrug resistant carcinoma cells. Cancer Res., 56: 3490-3494. (Pubitemid 26251642)
43. Yao J, Lu Y and Zhou JP (2008). Preparation of nobiletin in self-microemulsifying systems and its intestinal permeability in rats. J. Pharm. Pharm. Sci., 11: 22-29.
44. Yumoto R, Murakami T, Nakamoto Y, Hasegawa R, Nagai J and Takano M (1999). Transport of rhodamine 123, a P-glycoprotein substrate, across rat intestine and Caco-2 cell monolayers in the presence of cytocrome P-450 3A - related compounds, J. Pharmacol. Exp. Ther., 289: 149-155. (Pubitemid 29156023)
45. Zakeri-Milani P, Valizadeh H, Tajerzadeh H, Azarmi Y, Islambolchilar Z, Barzegar S and Barzegar-Jalali M (2007). Predicting human intestinal permeability using single-pass intestinal perfusion in rat. J. Pharm. Pharm. Sci., 10: 368-379. (Pubitemid 350065177)
46. Zhang H, Yao M, Morrison RA and Chong S (2003). Commonly used surfactant, Tween 80, improves absorption of P-glycoprotein substrate, digoxin, in rats. Arch. Pharm. Res., 26: 768-772. (Pubitemid 43073795)
47. Zhao YH, Abraham MH, Le J, Hersey A, Luscombe CN, Beck G, Sherborne B and Cooper I (2003). Evaluation of rat intestinal absorption data and correlation with human intestinal absorption. Eur. J. Med. Chem., 38: 233-243. (Pubitemid 36349666)